{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-RYP2FIFP/19649aaa-ada0-4784-9324-e81126d42f25/HTML","dcterms:extent":"19 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-RYP2FIFP/7a756f1b-e202-499e-964e-ca71443bc3f1/PDF","dcterms:extent":"116 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-RYP2FIFP/f73ad11d-601f-471d-897d-ccf5aeeefdb1/TEXT","dcterms:extent":"15 KB"}],"edm:TimeSpan":{"@rdf:about":"2002-2026","edm:begin":{"@xml:lang":"en","#text":"2002"},"edm:end":{"@xml:lang":"en","#text":"2026"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:DOC-RYP2FIFP","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/urn:nbn:si:spr-py0w57lr"},{"@xml:lang":"sl","#text":"Zdravstveno varstvo"}],"dcterms:issued":"2005","dc:creator":["Božanić, Vinko","Dermota, Urška","Franko-Kancler, Tatjana","Harlander, Tatjana","Kavčič, Martina","Ribič, Helena","Sarjanović, Ljudmila","Štrumbelj, Iztok"],"dc:format":[{"@xml:lang":"sl","#text":"številka:2"},{"@xml:lang":"sl","#text":"letnik:44"},{"@xml:lang":"sl","#text":"str. 69-73"}],"dc:identifier":["ISSN:0351-0026","COBISSID:1386981","URN:URN:NBN:SI:doc-RYP2FIFP"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Inštitut za varovanje zdravja Republike Slovenije"},"dc:subject":[{"@xml:lang":"en","#text":"antibiotic"},{"@xml:lang":"sl","#text":"antibiotiki"},{"@xml:lang":"en","#text":"bacteria"},{"@xml:lang":"sl","#text":"bakterije"},{"@xml:lang":"en","#text":"microbiology"},{"@xml:lang":"sl","#text":"mikrobiologija"},{"@xml:lang":"sl","#text":"odpornost"},{"@xml:lang":"en","#text":"Streptococcus pyogenes"}],"dcterms:temporal":{"@rdf:resource":"2002-2026"},"dc:title":{"@xml:lang":"sl","#text":"Streptococcus pyogenes - porast odpornosti izolatov iz dihal leta 2003| Streptococcus pyogenes - increase of antimicrobial resistance in respiratory tract isolates in 2003|"},"dc:description":[{"@xml:lang":"sl","#text":"Objective: To determine antimicrobial resistance rates in Streptococcus pyogenes respiratory specimens collected in Slovenia in 2003. Methods: In 2003, eight microbiology laboratories in Slovenia determined susceptibility toseveral antimicrobials and phenotype of resistance to macrolides and lincosamides in 887 S. pyogenes isolates from the respiratory tract. Results:All strains were susceptible to penicillin and vancomycin. The resistance rate to tetracycline was 6%, to erythromycin 10.8% and to clindamycin 9.5 %. All three macrolide resistance phenotypes were found and marked differences between the regions studied were noted. The established rates of resistance to macrolides and clindamycin were higher than in the years 2001 and 2002. Conclusions: Increased resistance to macrolide antibiotics and to clindamycin established in 2003, and the current rates of macrolide resistance are a cause for concern and call for immediate action to prevent high antibiotic resistance"},{"@xml:lang":"sl","#text":"Namen: Ugotoviti delež proti antibiotikom odpornih sevov pri izolatih Streptococcus pyogenes, osamljenih iz dihal v letu 2003. Metode: V osmih slovenskih mikrobioloških laboratorijih so v letu 2003 iz dihal osamili 887 izolatov vrste Streptococcus pyogenes. Pri sevih so določili občutljivost za izbrane antibiotike in fenotip makrolidno-linkozamidne odpornosti. Rezultati:Vsi izolati so bili občutljivi za vankomicin in penicilin. Delež odpornosti proti tetraciklinu je bil 6 %, proti eritromicinu 10,8 % in proti klindamicinu 9,5 %. Našli so vse tri fenotipe odpornosti proti makrolidom in ugotovili velike razlike med regijami. Odpornost proti makrolidom in klindamicinu je bila pogostejša kot v letih 2001 in 2002. Zaključek: Ugotovljeni deleži odpornih sevov proti makrolidnim antibiotikom in klindamicinu in trend naraščanja odpornosti v letu 2003 so razlogi za zaskrbljenost. Potrebni so ukrepi za preprečevanje odpornosti"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:DOC-RYP2FIFP","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:DOC-RYP2FIFP"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:DOC-RYP2FIFP/7a756f1b-e202-499e-964e-ca71443bc3f1/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Inštitut za varovanje zdravja RS"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:DOC-RYP2FIFP/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:DOC-RYP2FIFP"}}}}